Publications by authors named "Yoshimasa Ando"

Claim this Profile
T
Treatment outcomes of patients with neovascular age-related macular degeneration after switching from aflibercept to faricimab.
Yuji Oshima, Natsuki Himeno, Takehiko Nakamura, Yoshimasa Ando, Norifumi Takaki

Jpn J Ophthalmol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic Features, Diagnoses and Real-World Clinical Management of Uveitis in Japan.
Isami Hayashi, Hiroshi Keino, Makiko Nakayama, Yoshimasa Ando, Takayo Watanabe

Ocul Immunol Inflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin susceptibility of Staphylococci from conjunctiva in patients with atopic dermatitis.
Yumi Kusumi, Yoshimasa Ando, Chika Shigeyasu, Masaki Fukui, Masakazu Yamada

Jpn J Ophthalmol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
Makiko Nakayama, Annabelle A Okada, Isami Hayashi, Yoshimasa Ando, Takayo Watanabe

Ocul Immunol Inflamm· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.
Katsuya Nagahori, Hiroshi Keino, Makiko Nakayama, Takayo Watanabe, Yoshimasa Ando

Graefes Arch Clin Exp Ophthalmol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Vitreous microRNA as Possible Biomarker in High Myopic Eyes with Macular Hole.
Yoshimasa Ando, Hiroshi Keino, Makoto Inoue, Kazunari Hirota, Hiroyuki Takahashi

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features, Treatment, and Visual Outcomes of Japanese Patients with Posterior Scleritis.
Yoshimasa Ando, Hiroshi Keino, Makiko Nakayama, Takayo Watanabe, Annabelle A Okada

Ocul Immunol Inflamm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Inflammatory Effect of Dehydroxymethylepoxyquinomicin, a Nuclear factor-κB Inhibitor, on Endotoxin-Induced Uveitis in Rats In vivo and In vitro.
Yoshimasa Ando, Hiroshi Keino, Akihiko Kudo, Akito Hirakata, Annabelle A Okada

Ocul Immunol Inflamm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti‑inflammatory effects of the NF‑κB inhibitor dehydroxymethylepoxyquinomicin on ARPE‑19 cells.
Yoshimasa Ando, Yasuhiko Sato, Akihiko Kudo, Takayo Watanabe, Akito Hirakata

Mol Med Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment.
Yoshimasa Ando, Akito Hirakata, Arisa Ohara, Reiji Yokota, Tadashi Orihara

Graefes Arch Clin Exp Ophthalmol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MACULAR DETACHMENT ASSOCIATED WITH INTRACHOROIDAL CAVITATION IN NONPATHOLOGICAL MYOPIC EYES.
Yoshimasa Ando, Makoto Inoue, Kyoko Ohno-Matsui, Yumi Kusumi, Tomohiro Iida

Retina· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetrical recovery of cone outer segment tips line and foveal displacement after successful macular hole surgery.
Yuji Itoh, Makoto Inoue, Tosho Rii, Yoshimasa Ando, Akito Hirakata

Invest Ophthalmol Vis Sci· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis